News

A phase 3 clinical trial presented at the American Heart Association’s 2025 Scientific Sessions reveals that enlicitide, an investigational oral PCSK9 inhibitor, reduces LDL cholesterol by up to 60% in…

A University of Minnesota Medical School study published today in Mayo Clinic Proceedings reveals that accessing wheelchairs through Medicare-listed providers is inconsistent and often challenging. Using a secret shopper approach where…

A Phase 3 clinical trial in Gabon, West Africa, demonstrated that a single-dose combination therapy achieved 93% cure rates in malaria patients, presenting a potential breakthrough in combating drug resistance…

A comprehensive review published on June 8, 2025, in the World Journal of Pediatric Surgery provides groundbreaking insights into the syndromic forms of biliary atresia (BA), revealing shared genetic and embryological…

A randomized controlled trial from Stanford University School of Medicine demonstrates that personalized prehabilitation coaching significantly reduces postoperative complications and enhances immune readiness before major surgery. Published November 12 in JAMA…

A new report from the American Cancer Society (ACS) shows that lung cancer screening among high-risk adults in the United States remains strikingly low, even as smoking rates continue to…

A multicenter international trial led by researchers from the University of Calgary indicates that automated insulin delivery (AID) technology can improve glucose control during pregnancy for people with Type 1…

Before the Affordable Care Act (ACA), student health coverage varied widely. Many young adults could stay on a parent’s health plan only if they were enrolled full-time, and most plans…

A busy day at Michigan State University’s Dental Clinic highlighted a community-driven effort to provide free dental care to former service members. The event is part of the clinic’s ongoing…

Germany’s private health insurance market offers expatriates broader access to specialists, shorter waiting times, and more personalized care. For international residents, many providers tailor plans with English-speaking support, global coverage,…

A recent study challenges the default urge to treat every narrowed coronary artery during a heart-attack procedure. The findings suggest that, in many cases, it is safe to postpone nonblocked…

The number of people diagnosed with tuberculosis (TB) worldwide surged in 2024, surpassing the previous record set in 2023, according to the World Health Organization (WHO). This trend signals both…

As the flu season begins, global health authorities are increasingly concerned about a new influenza strain that emerged in June—four months after this year’s vaccine formulations were finalized. The strain,…

Researchers at Mayo Clinic’s Center for Individualized Medicine have identified a rare genetic mutation that can directly cause metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver…

The UK’s private healthcare sector is experiencing unprecedented growth as the National Health Service (NHS) grapples with soaring waiting lists and stretched public resources. With elective treatment queues in England…

Indiana-based pharmaceutical giant Eli Lilly has secured exclusive worldwide rights to a groundbreaking gene therapy, AAV-AIPL1, targeting Leber congenital amaurosis 4 (LCA4). LCA4 is a rare genetic disorder that causes…

Cardiovascular disease (CVD) remains the leading cause of death in the European Union (EU). According to the European Society of Cardiology, more than 1.7 million people in the EU died…

A research team at Arizona State University has developed a novel method to stabilize synthetic gene circuits by harnessing nature’s principle of liquid-liquid phase separation, addressing a critical challenge in…

A comprehensive analysis published today in Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists, challenges longstanding preferences for regional anesthesia during cesarean deliveries. Conducted by researchers from the…

A study published on November 6, 2025, in Oncotarget(Volume 16) reveals that LRIG1 protein expression significantly decreases in higher-grade gliomas, suggesting its potential as both a biomarker for tumor aggressiveness and…